Nurse Practitioner, Family · Flowood, MS
NPI
1376072413
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2510 Lakeland Dr
Flowood, MS, 39232
Phone (601) 355-1234
Groups this clinician bills Medicare through
Medicare paid, 2024
$120K
7,168 services
Medicare patients, 2024
267
Average age 70
Drug cost, 2024
$22.1M
2,287 prescriptions
Company payments, 2025
$133K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maranda Dillon was code 80053 (clinical chemistry), 928 times for 218 patients. In total Maranda Dillon billed 7,168 services in 40 codes, and Medicare paid $120K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80053 Clinical Chemistry | Office | 928 | 218 | $10.30 | $9,557 |
| 85025 Blood Count | Office | 922 | 219 | $7.58 | $6,988 |
| 86140 Clinical Chemistry | Office | 907 | 215 | $5.06 | $4,590 |
| 99214 Office E&M - Established | Office | 192 | 134 | $64.20 | $12K |
| 99213 Office E&M - Established | Office | 177 | 111 | $49.03 | $8,677 |
| 87340 Immunoassay | Office | 162 | 156 | $10.12 | $1,639 |
| 83540 Clinical Chemistry | Office | 102 | 83 | $6.30 | $643 |
| 84466 Clinical Chemistry | Office | 101 | 83 | $12.41 | $1,253 |
| 82728 Clinical Chemistry | Office | 98 | 80 | $13.27 | $1,300 |
| 99215 Office E&M - Established | Office | 63 | 57 | $95.69 | $6,029 |
| 82306 Clinical Chemistry | Office | 57 | 54 | $29.01 | $1,654 |
| 82607 Clinical Chemistry | Office | 48 | 46 | $14.49 | $695 |
| 82746 Clinical Chemistry | Office | 46 | 44 | $14.11 | $649 |
| 36415 Venipuncture Blood Collection | Office | 13 | 12 | $8.65 | $112 |
| 74177 CT/CTA - Abdomen and Pelvis | Office | 12 | 11 | $150.32 | $1,804 |
By year: 2022 $153K for 6,782 services; 2023 $142K for 7,815 services; 2024 $120K for 7,168 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 928 | 218 | $10.30 | $9,557 |
| 85025 Blood Count | 922 | 219 | $7.58 | $6,988 |
| 86140 Clinical Chemistry | 907 | 215 | $5.06 | $4,590 |
| 87340 Immunoassay | 162 | 156 | $10.12 | $1,639 |
| 83540 Clinical Chemistry | 102 | 83 | $6.30 | $643 |
| 84466 Clinical Chemistry | 101 | 83 | $12.41 | $1,253 |
| 82728 Clinical Chemistry | 98 | 80 | $13.27 | $1,300 |
| 82306 Clinical Chemistry | 57 | 54 | $29.01 | $1,654 |
| 82607 Clinical Chemistry | 48 | 46 | $14.49 | $695 |
| 82746 Clinical Chemistry | 46 | 44 | $14.11 | $649 |
Medicare prescription drug claims, 2024
In 2024, the drug Maranda Dillon prescribed most often to Medicare patients was Stelara (Ustekinumab), with 656 prescriptions and refills. In total Maranda Dillon wrote 2,287 Medicare prescriptions that cost $22.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 656 | 901 | 100 | $18.0M |
| Sodium Chloride 0.9 % Sodium Chloride | 220 | 220 | 46 | $978 |
| Omeprazole Generic | 133 | 248 | 38 | $1,357 |
| Remicade Infliximab | 125 | 176 | 18 | $1.2M |
| Entyvio Vedolizumab | 102 | 144 | 18 | $869K |
| Mesalamine Generic | 77 | 102 | 23 | $25K |
| Sulfasalazine Generic | 69 | 131 | 21 | $1,791 |
| Mesalamine Er Mesalamine | 63 | 94 | 17 | $12K |
| Famotidine Generic | 58 | 143 | 25 | $1,009 |
| Humira(Cf) Pen Adalimumab | 49 | 55 | Under 11 | $560K |
| Rinvoq Upadacitinib | 44 | 50 | Under 11 | $368K |
| Pantoprazole Sodium Generic | 42 | 80 | 14 | $372 |
| Azathioprine Generic | 34 | 64 | Under 11 | $553 |
| Dicyclomine Hcl Generic | 33 | 45 | 22 | $639 |
| Methotrexate Methotrexate Sodium | 29 | 29 | Under 11 | $226 |
Brand drugs: 1,455 claims; generic drugs: 832 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maranda Dillon $133K ($130K in general payments such as food, travel and fees and $2,901 for research) from 15 companies. The largest payer was Janssen Biotech, Inc. with $84K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 135 | $84K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 40 | $18K |
| Abbvie Inc. ABBV | 56 | $14K |
| Lilly USA, LLC LLY | 16 | $5,515 |
| Celltrion USA Inc. 068270.KS | 14 | $3,338 |
| Sanofi US Services Inc. SNY | 11 | $2,901 |
| Genentech USA, Inc. ROG.SW | 4 | $2,768 |
| Janssen Scientific Affairs, LLC JNJ | 14 | $878 |
| Merck Sharp & Dohme LLC MRK | 7 | $729 |
| Pfizer Inc. PFE | 8 | $444 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.